Loading...
Heart Test Laboratories, Inc.
HSCSW•NASDAQ
Healthcare
Medical - Devices
$0.14
$0.09(161.58%)
Heart Test Laboratories, Inc. (HSCSW) Stock Overview
Explore Heart Test Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
261.17%
↑ 261.17%
Profit Growth
$-2578.22
↑ 98.65%
EPS Growth
$-2578.22
↑ 99.70%
Operating Margin
0.00%
↓ 3.15%
ROE
-174.83%
↑ 98.65%
Dividend Yield
0.00%
Analyst Recommendations data is not available for HSCSWAnalyst Recommendations details for HSCSW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
CEO
Mr. Andrew Simpson
Employees
15
Headquarters
550 Reserve Street, Southlake, TX
Founded
2022